Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics.
Caterina CandelaAngelo Roberto RaccagniElena BruzzesiCostanza BertoniAlberto RizzoGloria GagliardiDiana CanettiNicola GianottiDavide MiletoMaria Rita GismondoAntonella CastagnaSilvia Nozzanull nullPublished in: Viruses (2023)
Similarly to other international cohorts, sexual transmission was most frequently present, and concomitant STIs were common. Symptoms were heterogenous, self-resolving and responsive to therapy. Hospitalization was necessary in few patients. There is uncertainty about the future development of mpox and further studies (e.g., potential disease reservoirs, other possible means of transmission, predictors of severe disease) are still needed.
Keyphrases
- end stage renal disease
- chronic kidney disease
- endothelial cells
- ejection fraction
- newly diagnosed
- healthcare
- prognostic factors
- peritoneal dialysis
- induced pluripotent stem cells
- climate change
- stem cells
- cancer therapy
- early onset
- current status
- depressive symptoms
- human health
- patient reported outcomes
- sleep quality
- acute care
- adverse drug